We crossed fields, played in trees, tracked coyotes, built mud forts in ditch banks, and watched giant frogs crush our dirt village
Every PT-141 batch is HPLC-verified and supplied with batch-level COA documentation
The first animal studies showing that GLP-1 potentially had effects on the CV system was published in 2002, and the first study to show cardioprotection was in 2008 (102, 211), but it was not until the LEADER cardiovascular outcomes trial (CVOT) with liraglutide, published in 2016, that a reduction in CV risk with a GLP-1RA was documented (100)
10.3390/v14050986 114 RajewskiP.CiescinskiJ.RajewskiP.SuwalaS.RajewskaA.PotaszM
Im using it. If you're already on Ozempic or Wegovy and wondering how to adjust your training as the weight comes off, read our guide on how to adjust your workouts on Ozempic or Wegovy
Patients with heart disease, high blood pressure, or cardiovascular risk factors Patients with liver disease or abnormal liver enzymes Patients with hormone-sensitive conditions Patients with fertility concerns or active family-planning goals Patients with a history of mood disorders, aggression, anxiety, or depression Patients taking medications that may interact with hormone or metabolic pathways Competitive athletes subject to drug testing rules Anyone considering products labeled research use only or sold without medical oversight A medical consultation can help determine whether peptide therapy, hormone testing, lifestyle changes, recovery support, or another treatment is the safer fit
